Advertisement

Loading...

nDatalyze Corp.

NDAT.CNCNQ
Healthcare
Medical - Healthcare Information Services
$0.07
$-0.02(-23.53%)
Canadian Market opens in 8h 26m

nDatalyze Corp. Fundamental Analysis

nDatalyze Corp. (NDAT.CN) shows weak financial fundamentals with a PE ratio of -18.91, profit margin of 0.00%, and ROE of -34.06%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position18.58%
PEG Ratio-0.61
Current Ratio21.60

Areas of Concern

ROE-34.06%
Operating Margin0.00%
We analyze NDAT.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5.1/100

We analyze NDAT.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

NDAT.CN struggles to generate sufficient returns from assets.

ROA > 10%
-35.34%

Valuation Score

Excellent

NDAT.CN trades at attractive valuation levels.

PE < 25
-18.91
PEG Ratio < 2
-0.61

Growth Score

Weak

NDAT.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NDAT.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
21.60

Profitability Score

Weak

NDAT.CN struggles to sustain strong margins.

ROE > 15%
-3406.04%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is NDAT.CN Expensive or Cheap?

P/E Ratio

NDAT.CN trades at -18.91 times earnings. This suggests potential undervaluation.

-18.91

PEG Ratio

When adjusting for growth, NDAT.CN's PEG of -0.61 indicates potential undervaluation.

-0.61

Price to Book

The market values nDatalyze Corp. at 7.00 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.00

EV/EBITDA

Enterprise value stands at -21.74 times EBITDA. This is generally considered low.

-21.74

How Well Does NDAT.CN Make Money?

Net Profit Margin

For every $100 in sales, nDatalyze Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-34.06 in profit for every $100 of shareholder equity.

-34.06%

ROA

nDatalyze Corp. generates $-35.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

-35.34%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

NDAT.CN converts -5.41% of its market value into free cash.

-5.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-18.91

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.61

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

21.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.34

vs 25 benchmark

ROA

Return on assets percentage

-0.35

vs 25 benchmark

ROCE

Return on capital employed

-0.52

vs 25 benchmark

How NDAT.CN Stacks Against Its Sector Peers

MetricNDAT.CN ValueSector AveragePerformance
P/E Ratio-18.9128.31 Better (Cheaper)
ROE-34.06%699.00% Weak
Net Margin0.00%-130884.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio21.602775.16 Strong Liquidity
ROA-35.34%-14469.00% (disorted) Weak

NDAT.CN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews nDatalyze Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ